control group:conbercept

2 trials

Sponsors

Department of Ophthalmology, Central Theater Command General Hospital,, Nanjing Lishui People's hospital

Conditions

Central retinal vein occlusionretinal vein occlusion

Early Phase 1

Clinical efficacy of atorvastatin combined with conbercept in the treatment of patients with retinal vein occlusion macular edema and carotid artery plaques

Active, not recruitingChiCTR2300071359

Nanjing Lishui People's hospitalretinal vein occlusion

Start: 2023-07-01Updated: 2023-06-12

Phase 3

A 12-month clinical study of conbercept combined with Intravitreal Dexamethasone (DEX) Implant in the treatment of macular edema secondary to central retinal vein occlusion

RecruitingChiCTR2000040087

Department of Ophthalmology, Central Theater Command General Hospital,Central retinal vein occlusion

Start: 2020-06-08Updated: 2021-01-05

Related Papers

Clinical effects of atorvastatin combined with conbercept in the treatment of patients with macular edema secondary to retinal vein occlusion and carotid plaque: study protocol for a prospective randomized controlled trial.

2024-04-082 citations